Y.-Y. Niu et al. / Bioorg. Med. Chem. 16 (2008) 10251–10256
10255
Table 2
(s, 3H, CH3N), 1.54–3.3 (m, 6H, 2, 4, 7-H), 3.40–3.80 (m, 2H, 1, 5-H),
5.40–5.90 (m, 2H, 3, 6-H), 8.20–8.60 (m, 4H, Ph-H).
Binding affinities for rat submandibulary gland of (6S)-2, (6R)-2, (6S)-3, (6R)-3, (6S)-4,
or (6R)-4.
Compound
Submandibulary glandsa
Ki ( M)
4.3.3. (6S), (6R)-3a-Benzenesulfonyloxy-6b-acetoxytropane (4)
Pale yellow oil, (6S)-4, (168 mg, 35%), ½a D20
ꢂ
ꢀ6.1°(c, 1.60, CHCl3);
l
(6R)-4, (155 mg, 27%), ½a D20
ꢂ
+5.9° (c, 1.35, CHCl3). IR (KBr) cmꢀ1
:
(6S)-2
(6R)-2
(6S)-3
(6R)-3
(6S)-4
(6R)-4
9.0 1.1
73 22
3.70 0.51
450 34
0.040 0.003
—
2948, 2858, 1733, 1586. EI-MS m/z: 339 (M+, 8.56), 182, 122, 94,
82, 43. 1H NMR (CDCl3, 400 MHz) d: 1.76–2.60 (m, 6H, 2,4,7-H),
2.04 (s, 3H, CH3CO), 2.54 (s, 3H, CH3N), 3.17 (s, 1H, 5-H), 3.42 (m,
1H, 1-H), 4.80 (m, 1H, 3-H), 5.45 (dd, J = 3.0, 6.4 Hz, 1H, 6-H),
7.34–7.70 (m, 3H, Ph-H), 7.86–7.95 (m, 2H, Ph-H).
a
The Kd (dissociation constant), Bmax (maximal number of binding sites) and Hill
coefficient of H-labelled N-methylscopolamine are: 0.71 nM, 70.5 (fmol/mg wet
weight), 0.92. ‘‘—”: not detected.
4.4. Functional in vitro studies
(6S)-4 and (6R)-4 were tested for stimulating the contraction
of isolated iris muscle as agonistic activity, while (6S)-2, (6R)-2,
(6S)-3, and (6R)-3 for inhibiting the carbachol-induced contrac-
tion of isolated iris muscle as antagonistic activity. Guinea-pigs
(250–350 g) of either sex provided by animal experimental center
of Shanghai Jiao Tong University were killed by a blow to the
head and exsanguinated. The ileal longitudinal muscle was rap-
idly removed and gently cleaned of adhering connective tissue
in a prewarmed (37 °C) and oxygenated (95%O2 + 5%CO2) medium
of the Kreb’s solution of the following composition: NaCl 6.6 g,
CaCl2 0.28 g, KCl 0.35 g, MgSO4ꢃ7H2O 0.294 g, KH2PO4 0.162 g,
NaHCO3 2.1 g, glucose 2.0 g in 1000 ml distilled water. Strips of
ileal longitudinal muscle (1.5 cm) prepared were transferred to
10 ml organ baths and loaded with a tension of 500 mg. The prep-
aration was allowed to equilibrate for 30 min, changing the bath
fluid every 10 min. Contractions were recorded isotonically with
an electromechanical transducer connected to Bridge amplifier
and Powerlab system recorder. Cumulative concentration–re-
sponse curves were obtained for carbachol, (6S)-4, (6R)-4. The
concentration of agonist in the organ bath was increased approx-
imately 3-fold at each step, with each addition being made only
after the response to the previous addition had attained a maxi-
mal level and remained steady. The contractile responses of iris
muscle to each dose of the muscarinic agonists were expressed
as percentages of the maximum effect induced by carbachol.
For the antagonistic test, after stable concentration-response
curves for carbachol was obtained, (6S)-2, (6R)-2, (6S)-3, or
(6R)-3 was added and the tissue was stimulated cumulatively
with carbachol as before. Three different concentrations of (6S)-
2, (6R)-2, (6S)-3, or (6R)-3 were investigated.
Table 3
Mydriatic or myotic effect caused by (6S)-2, (6R)-2, (6S)-3, (6R)-3, (6S)-4, or (6R)-4.
Compound
Percentage of the pupil
diameter changing (%)
Control
(6S)-2
(6R)-2
(6S)-3
(6R)-3
(6S)-4
(6R)-4
2.7 0.5*
32.2 1.9*
3.0 1.5
35.1 2.1*
3.7 1.3
ꢀ44.0 3.1*
ꢀ4.7 2.2
The positive values represent mydriatic effect, while the negative myotic effect. The
left pupil diameters (mm) of the rabbits were measured under constant light, and
readings were taken before and at 10 min after dropping 0.05 ml agent, while the
right for the control as reference. *P < 0.05.
The residue 2.980 g with 5.442 g (15.2 mmol) (ꢀ)-2,3-dibenzoyl-
L-
tartaric acid in 20 ml isopropanol, treated as mentioned above,
7.022 g (40%) salt as white needle crystals were obtained, mp
180–181 °C, ½a 2D0
ꢀ63.2° (c, 0.95, H2O), followed by getting the col-
ꢂ
orless oil 2.320 g (37%), (6R)-5, ½a D20
ꢂ
+19.9° (c, 1.02, CHCl3).
4.3. General procedure for the preparation of enantiomers of 2,
3, and 4
Equimolar quantity of (6S)-5 or (6R)-5 was dissolved in 2 ml
CH2Cl2 with 0.1 ml pyridine. The 0.3–0.5 ml acid chloride was then
added dropwise while stirring at room temperature during 4–12 h.
The reaction liquor was evaporated in vacuo. The residue was dis-
solved in water and adjusted with concentrated ammonium
hydroxide to pH 9–10. The solution was extracted with CH2Cl2
(5ꢁ 6 ml). The organic phase was dried over anhydrous sodium
sulfate and evaporated to dryness. The crude product was purified
by column chromatography over silica gel. Dichloromethane/
methanol (25:1) eluted the pure ester.
4.5. Radioreceptor binding assays
The binding of (6S)-2, (6R)-2, (6S)-3, (6R)-3, (6S)-4, or (6R)-4 to
mAChR was determined using the submandibulary glands of the
rat. A male SD rat (220–240 g) was killed by cervical dislocation.
The submandibulary glands were removed, cleaned adhering tis-
sue in ice-cold 50 mM Tris buffer (pH 7.4). Homogenisation of
the submandibulary glands was carried out in 1 g:20 ml (w:v) vol-
ume ice-cold 0.32 M sucrose in Tris buffer using a Waring blender
and further disrupted with an Ultraturrax Tissuemizer. The crude
homogenate was centrifuged for 10 min at 1000g and the resulting
supernatant was centrifuged for 30 min at 20,000g to yield a mem-
brane pellet. The pellet was resuspended in Tris buffer as a crude
membrane fraction. All the procedures were performed at 4 °C. In
the saturation binding assay, membranes (0.1 mg protein) were
incubated vibrantly at 37 °C for 30 min in 0.078–1.55 nM
4.3.1. (6S), (6R)-3a-Parachlorobenzoyloxy-6b-acetoxytropane
(2)
Pale yellow oil, (6S)-2, (191 mg, 65%), ½a D20
ꢂ
+20.2° (c, 0.40,
CHCl3); (6R)-2 (231 mg, 71%), ½a D20
ꢀ19.8° (c, 0.53, CHCl3). IR
ꢂ
(KBr) cmꢀ1: 2939, 2857, 1732, 1592. EI-MS m/z: 337 (M+), 182,
122, 94, 82, 43. 1H NMR (CDCl3, 400 MHz) d: 1.98 (s, 3H, CH3CO),
2.56 (s, 3H, CH3N), 1.18–2.77 (m, 6H, 2, 4, 7-H), 3.2–3.6 (m, 2H,
1, 5-H), 5.1–5.4 (m, 1H, 3-H), 5.53 (dd, 1H, J = 4.0, 8.0 Hz, 6-H),
7.38 (d, 2H, J = 14 Hz, Ph-H), 7.92 (d, 2H, J = 14 Hz, Ph-H).
[3H]NMS with or without 10
lM atropine sulfate in a total volume
4.3.2. (6S), (6R)-3a-Paranitrobenzoyloxy-6b-acetoxytropane (3)
Pale yellow oil, (6S)-3, (268 mg, 51%), ½a D20
ꢂ
+30.9° (c, 1.05, CHCl3);
of 0.4 ml. The reaction was terminated by rapid filtration through
glass fiber filters, washed three times with ice-cold Tris buffer.
The protein concentration was determined with the micro BCA
kit (Pierce, Rockford, IL), using bovine serum albumin as the stan-
(6R)-3 (202 mg, 66%), ½a D20
ꢂ
ꢀ30.7° (c, 1.15, CHCl3). IR (KBr) cmꢀ1
:
2938, 2857, 1732, 1609. EI-MS m/z: 348 (M+, 8.07), 182, 149, 122,
94, 82, 43. 1H NMR (CDCl3, 400 MHz) d: 2.34 (s, 3H, CH3CO), 2.82